Skip to main content
Journal of Medical Microbiology logoLink to Journal of Medical Microbiology
. 2025 Jan 6;74(1):001942. doi: 10.1099/jmm.0.001942

Investigating the time to blood culture positivity: why does it take so long?

Kerry Falconer 1,*, Robert Hammond 1, Benjamin J Parcell 1,2, Stephen H Gillespie 1
PMCID: PMC11701752  PMID: 39757997

Abstract

Introduction. Bloodstream infections (BSIs) are one of the most serious infections investigated by microbiologists. However, the time to detect a BSI fails to meet the rapidity required to inform clinical decisions in real time.

Gap Statement. Blood culture (BC) is considered the gold standard for diagnosing bloodstream infections. However, the time to blood culture positivity can be lengthy. Underpinning this is the reliance on bacteria replicating to a high concentration, which is necessary for the detection using routine blood culture systems. To improve the diagnosis and management of patients with BSIs, more sensitive detection methods are required.

Aim. The study aimed to answer key questions addressing the delay in BSI detection and whether the time to BSI detection could be expedited using a Scattered Light Integrated Collection (SLIC) device.

Methodology. A proof-of-concept study was conducted to compare the time to positivity (TTP) of Gram-negative BCs flagging positive on BacT/ALERT with an SLIC device. An SLIC device was utilized to compare the TTP of the most prevalent BSI pathogens derived from nutrient broth and BC, the influence of bacterial load on TTP and the TTP directly from whole blood. Additionally, the overall turnaround time (TAT) of SLIC was compared with that of a standard hospital workflow.

Results. Most pathogens tested took significantly longer to replicate when derived from BC than from nutrient medium. The median TTP of Gram-negative BC on BacT/ALERT was 13.56 h with a median bacterial load of 6.4×109 c.f.u. ml−1. All pathogens (7/7) derived from BC at a concentration of 105 c.f.u. ml−1 were detectable in under 70 min on SLIC. Decreasing Escherichia coli BC concentration from 105 to 102 c.f.u. ml−1 increased the TTP of SLIC from 15 to 85 min. Direct BSI detection from whole blood on SLIC demonstrated a 76% reduction in TAT when compared with the standard hospital workflow.

Conclusion. An SLIC device significantly reduced the TTP of common BSI pathogens. The application of this technology could have a major impact on the detection and management of BSI.

Keywords: blood culture, bloodstream infection, rapid diagnostics

Introduction

Bloodstream infections are life-threatening and time-sensitive [1,2]. However, the time to detect positive blood culture (BC) is lengthy and presents a major challenge in managing patients effectively [3,5]. The diagnosis of bloodstream infection (BSI) requires confirmation of viable bacteria in the bloodstream [6]. As the circulating levels of bacteria in patients with BSI are typically very low (1–100 c.f.u. ml−1), the confirmation of infection is reliant on bacterial replication in vitro [7,8]. A blood volume of 20–30 ml is recommended to accurately detect BSI with two positive BCs from two different body sites recommended for a diagnosis [6]. Currently, clinical laboratories employ automated blood culturing systems, such as BACTEC, BacT/ALERT and VersaTrek to detect BC positivity. Automated blood culturing systems are normally dependent on the active metabolism of bacteria and detect the presence of bacteria either by detecting increasing levels of CO2 by changes in pH and utilization of carbohydrate substrates by fluorescence intensity or by measuring pressure changes via O2 consumption and production of other gases (CO2, N2 and H2) [9,11]. The time to positivity (TTP) using these platforms ranges from 10 to 19 h and requires up to 5 days to confirm BC negativity [5,12,15].

The typical presentation and symptoms of BSI such as fever, chills, low blood pressure, increased heart rate and fatigue overlap with a range of other illnesses and make confirmation by culture essential [16]. Prompt, optimal antimicrobial therapy is of critical importance in BSI to resolve the infection early and prevent the onset of systemic inflammatory syndrome and sepsis [17]. The need for prompt optimal antimicrobial therapy in BSI is, however, complicated by the time taken to reach the diagnosis and the ongoing global rise in antimicrobial-resistant infections [18,20]. Long turnaround time (TAT) for BC positivity and subsequent antimicrobial susceptibilities increase the patient’s vulnerability to misdiagnosis and antimicrobial treatment failures. This can lead to increased recovery times, longer hospital stays, worse health outcomes and heightened risk of mortality [21,26].

Central to improving the BSI diagnostic pathway is the development and adoption of technologies that can quickly detect a BSI and inform treatment within a clinically useful timeframe. A Scattered Light Integrated Collection (SLIC) device was designed and developed to facilitate sensitive monitoring of bacterial growth and has been shown previously to detect clinically significant pathogens rapidly [27]. This patented technology is an innovative combination of laser light scattering, locked signal and an integrating detection space. This unique combination allows the detection of small changes in the bacterial population to be detected through the real-time monitoring of total light scatter. This paper reports on the use of SLIC to expedite BSI detection in comparison to an automated blood culturing platform and evaluates the ability of SLIC to perform direct detection of a BSI from whole blood.

Methods

Time to positivity of BC using BacT/ALERT

Samples submitted to the microbiology service of the Ninewells Hospital were collected prospectively between 17 January 2019 and 9 May 2019. BCs on the BacT/ALERT system that signalled positive and were confirmed to be Gram-negative bacteria by Gram stain were included in the study. Positive BCs were flagged on the BacT/ALERT system when an increase in CO2 production occurred, an indicator of microbial growth. The BacT/ALERT system was checked regularly between 0730 and 2100. BCs have a maximum incubation period of 5 days unless a special request is made. The TTP on the BacT/ALERT system was recorded for all BCs.

Quantifying the bacterial load of flagged positive BCs on the BacT/ALERT system

Serial dilution plates were performed for all Gram-negative BCs. c.f.u. counts were undertaken immediately after an aliquot of BC was available and were performed using an adapted version of the Miles and Misra method [28] [28]. Briefly, 1 ml of BC was serially diluted between 10−1 and 10−10, and the last eight dilutions were plated in triplicate on brain heart infusion (BHI) agar and incubated overnight at 37 °C in aerobic conditions. c.f.u. counts were recorded the following morning.

Preparation of surrogate BC

Surrogate blood cultures (SBCs) were made using 8 ml of tryptic soy broth (TSB), 1 ml of defibrinated horse blood (HB035, TCS Biosciences) and 1 ml of bacterial culture. BCs were spiked with either Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Klebsiella pneumoniae ATCC 700603, Pseudomonas aeruginosa ATCC 27853, Acinetobacter baumannii ATCC 19606, Streptococcus agalactiae ATCC 12386 or Streptococcus pneumoniae ATCC 49619. A 1:10 blood–broth ratio was used to limit the antibacterial effects of blood in line with the UK Standards for Microbiology Investigations guidelines [29]. A final bacterial concentration of 105 c.f.u. ml−1 was used to spike all BCs. The bacterial concentration was confirmed by optical density (OD600) and c.f.u. plate counts.

The principle of SLIC

The SLIC method (v7) has been developed to capture total light scatter in real-time enabling high-resolution monitoring of bacterial populations. Cells undergoing replication, entering the stationary phase or cell death are recorded through changes in light scatter. The change in light scatter is detected by photodetectors within the integrated space and expressed in millivolts (mV). In the 6-well prototype used in this study, the unique scattering patterns were analysed across six wells simultaneously for each experiment. A detailed technical description of the SLIC device is provided in the following patents: GB201502194D0, GB201619509D0 and EP3759464A1. The patents are freely accessible online.

Measuring bacterial generation time and time to detection of BSI pathogens derived from BC and nutrient culture using SLIC

To understand how the time to BC positivity could be improved, SBCs spiked with different BSI pathogens were prepared as described above and were analysed on SLIC. The growth behaviours of these bacteria were studied in both the presence and absence of blood. The bacteria were recovered from BC using a low-speed serum separation tube (LS-SST) method as previously described [30]. The recovered bacteria were diluted 1:10 into fresh pre-warmed TSB to achieve a final bacterial concentration of 105 c.f.u. ml−1. Bacterial cultures were performed in triplicate on SLIC and analysed for 120 min. Bacterial growth was measured by total light scatter (mV) every second at 37 °C. Cultures of BSI pathogens grown in BHI media were also monitored on SLIC to determine the impact of blood on the bacterial generation time. Overnight culture was grown to a bacterial concentration of 108 c.f.u. ml−1, confirmed by an OD reading of 1.00 and serially diluted to achieve a final bacterial concentration of 105 c.f.u. ml−1 in pre-warmed BHI media on SLIC. Each SLIC run was performed for 60 min and was run in triplicate. Each run included three negative controls containing media only and three seeded cultures at a bacterial concentration of 105 c.f.u. ml−1.

The impact of bacterial concentration on the time to detection using SLIC

To measure the impact of bacterial load on the time to BC positivity, SBCs were spiked with different concentrations of E. coli and analysed directly on SLIC. E. coli ATCC 25922 was used as a model organism and was grown overnight from glycerol stock in 10 ml TSB and incubated at 37 °C. OD readings confirmed a bacterial concentration of 108 c.f.u. ml−1 (OD 1.00). The bacterial culture was serially diluted to achieve a final concentration range of between 102 and 105 c.f.u. ml−1 in BC. The bacterial concentration was confirmed by c.f.u. using BHI plate counts. Bacteria were recovered from BC using the LS-SST method as previously described [30]. The recovered bacteria were diluted 1:10 into pre-warmed TSB media, and bacterial growth was monitored on SLIC for 120 min. Three biological repeats were performed for each BC concentration. Each run included three negative controls containing media only and three seeded cultures at one of the following bacterial concentrations: 102, 103, 104 or 105 c.f.u. ml−1.

Direct detection of bacteria from whole blood using SLIC

To determine whether the detection of bacteria directly from a patient blood sample was achievable using SLIC, whole blood donated by healthy volunteers was spiked with very low concentrations of E. coli, one of the most prevalent BSI pathogens. Blood was donated by healthy volunteers within the School of Medicine at the University of St Andrews. A total of 40 ml of blood was taken at each blood donation by trained personnel. Blood was collected in a 10-ml ED vacutainer EDTA (K2) tube using an ED Vacutainer Safety-Lok blood collection set (Medisave, UK). Blood was stored at 4–6 °C until needed and was stored for a maximum of 6 days.

E. coli ATTC 29522 was grown overnight from glycerol stock in 10 ml TSB and incubated at 37 °C. OD readings were used to confirm a bacterial concentration of 108 c.f.u. ml−1 (OD 1.00). The bacterial culture was then diluted accordingly to achieve a final concentration range of between 1 and 1000 c.f.u. ml−1 in whole blood. The final spiked bacterial concentration was confirmed by c.f.u. using BHI plate counts as previously described [28]. Three different blood volumes were tested: 2 ml, 4 ml and 8 ml to mimic blood volumes used in automated blood culturing platforms.

The spiked blood was transferred to an 8.5-ml BD Vacutainer SST II Advance tube (Fisher Scientific, UK) containing 1 mg l−1 of polyantholesulfonic acid sodium salt (Sigma-Aldrich, Cat No: 444464, UK). The red blood cells were removed from the sample by LS-SST centrifugation as previously described [30]. The supernatant of the sample (serum) was transferred and diluted 1:50 using pre-heated TSB media and placed directly into SLIC. Each spiked sample was run in triplicate, and each run consisted of three negative controls (unseeded serum).

Comparison of standard of care and SLIC workflow

The time elapsed between sample collection and loading on the BacT/ALERT (transfer time) and the TTP of the BacT/ALERT system was measured for 79 E. coli BCs to calculate the mean TAT for the standard workflow. The TAT for SLIC was calculated using the maximum TTP measured in the study along with the processing times using the LS-SST recovery method.

Data analysis

The TTP of the BacT/ALERT system and the bacterial concentration in the flagged positive BC bottle are expressed as median with interquartile range (IQR). Data grouped by bacterial species is expressed as mean±sem. Data generated by SLIC are expressed as mean±sem. The TTP of SLIC was defined as the time taken to achieve a clear differentiation between the positive and negative control on SLIC (when two consecutive timepoints were above the baseline of the negative control). The TTP of SLIC is expressed as mean±sem.

All data analysis was performed using GraphPad Prism v9.3.0.

Data availability

Raw data were generated at the Ninewells Hospital, Dundee, and the University of St Andrews. Derived data supporting the findings of this study are available from the corresponding author (KF) on request.

Results

Time to positivity and bacterial load of Gram-negative BCs on the BacT/ALERT system

A total of 111 Gram-negative BCs flagged positive on the BacT/ALERT system in a median time of 13.56 h (IQR, 10.57–19.66) and varied with Gram-negative bacteria spp. (Fig. 1). The median Gram-negative bacterial concentration of flagged positive BCs was 6.4×109 c.f.u. ml−1 (IQR, 6.6×108–7.26×1010) (Fig. 2).

Fig. 1. The detection time (hours) of Gram-negative BSI using BacT/ALERT 3D system. A total of 111 Gram-negative BCs flagged positive on the BacT/ALERT system over the 5-month study with a median TTP of 13.56 h (IQR, 10.57–19.66). The TTP varied with bacterial spp. For bacteria spp. detected more than once, the number of cases is given [n] with the mean±sem.

Fig. 1.

Fig. 2. Quantifying the bacterial concentration of BCs that had flagged positive with Gram-negative bacteria. The median bacterial concentration for 109 Gram-negative BCs was 6.4×109 c.f.u. ml−1 (IQR, 6.6×108–7.26×1010). Two BCs, one positive for P. aeruginosa and another for Pantoea agglomerans, could not be quantified due to insufficient growth. For bacteria spp. detected more than once, the number of cases is given [n] with the mean±sem.

Fig. 2.

The impact of blood on bacterial generation time

After studying the TTP and bacterial load of positive BCs on the BacT/ALERT system, the next series of experiments looked more closely into the processes that underpin BC examination (Fig. 3). The increased sensitivity of SLIC provided an insight into bacterial growth rate when inoculated in culture media compared with BC. The TTP on SLIC was significantly longer for bacteria sub-cultured from BC compared with culture media except for S. aureus. SLIC enabled most bacteria (6/7) to be detectable in less than 60 min and within two bacterial replication cycles. The exception to this was S. agalactiae, which required greater than two generations and was detectable within 70 min.

Fig. 3. Comparison of TTP of different bacterial species grown in BC compared with BHI medium. TTP was defined as the time taken to achieve a clear differentiation between the positive and negative control on SLIC. The time to detection on SLIC was normalized by previously published generation times (Table S1, available in the online Supplementary Material). The TTP on SLIC was noticeably longer when bacteria were grown in BC compared with media except for S. aureus. All BSI pathogens were detectable on SLIC in under 60 min apart from S. agalactiae (70 min). The starting bacterial concentration was 105 c.f.u. ml−1.

Fig. 3.

The impact of bacterial load on time to BC positivity on SLIC

As one of the most prevalent BSI pathogens (20–30 % of cases worldwide), E. coli was used as a model pathogen to explore the impact of starting bacterial load on the time to BC positivity on SLIC. The time to BC positivity was measured for four different concentrations of E. coli (102–105 c.f.u. ml−1) over 120 min (Fig. 4). The most concentrated BC separated from the baseline almost immediately and reached exponential growth within 15 min. The lower concentrated BC demonstrated a steady increase in growth with small increases in mV readings on SLIC. At the lowest bacterial concentration of 102 c.f.u. ml−1, separation from the baseline occurred within 85 min.

Fig. 4. E. coli BCs spiked with four different concentrations were examined on SLIC over 120 min. The LS-SST method was used to recover bacteria from BC, and the bacteria were grown in pre-warmed TSB media for SLIC analysis. The TTP was determined when the mV output deviated from the baseline consistently for two timepoints (indicated in green). The baseline was defined by the negative control mV output (not shown on graph). A total of three biological repeats were performed at each BC concentration, the mean±sem is plotted. A concentration time-dependent relationship was established for all BCs. BCs spiked with E. coli at 105, 104 and 103 c.f.u. ml−1 were detectable within 15 to 30 min, respectively. In comparison, BC spiked with E. coli at 102 c.f.u. ml−1 was detectable within 85 min.

Fig. 4.

Direct detection of bacteria from spiked whole blood using SLIC

Having established the TTP from BC on SLIC, the study progressed to explore the direct detection of BSI from whole blood. E. coli was used as a model organism for these series of experiments. The LS-SST recovery method supported the direct detection of E. coli from whole blood. A concentration–time-dependent relationship was established with the highest bacteria load of 103 c.f.u. ml−1 detectable within 5 h and associated with the shortest TTP on SLIC (Fig. 5). The TTP did not significantly vary with blood volume when the bacterial concentration was above 10 c.f.u. ml−1. However, a bacterial load of <10 c.f.u. ml−1 was only detectable on SLIC when using the lowest blood volume of 2 ml with a TTP of 12.77 h.

Fig. 5. The TTP of E. coli on SLIC directly from whole blood. The mean TTP for a bacterial concentration range of 10–103 was 8.54±0.99 h, 6.48±0.81 h and 6.48±0.67 h for the blood volumes of 2 ml, 4 ml, and 8 ml respectively. The overall mean TTP across all bacterial concentrations and blood volumes was 7.16±0.82 h.

Fig. 5.

Time to detection of an E. coli BSI using the SLIC method compared with the BacT/ALERT workflow

To determine whether the direct processing of blood samples on SLIC would accelerate the time to the detection of an E. coli BSI, the SLIC TAT was directly compared with the standard workflow in a clinical setting. The longest TTP on SLIC of 12.77 h was associated with the smallest blood volume of 2 ml and the lowest bacterial concentration of <10 c.f.u. ml−1. For comparison, the mean TTP of E. coli BC on the BacT/ALERT system was 12.30±3.7 h. The TAT to confirm an E. coli BSI was 24.84±4.98 h using the standard BacT/ALERT workflow in comparison to the SLIC workflow with a maximum TAT of 12.94 h (Fig. 6).

Fig. 6. Time saving of the SLIC workflow against the BacT/ALERT workflow. The SLIC workflow involves the direct processing of whole blood with a 10-min serum separation step before the sample is ready for use in SLIC. The analysis of TTP on SLIC directly from whole blood was comparable to BacT/ALERT for the detection of E. coli. However, by directly sampling from whole blood (patient sample), the mean transfer time of 12.54±1.28 h was nullified and could potentially enable BC positivity to be confirmed within the same day as sampling. The slowest meantime for detection on SLIC (E. coli at <10 c.f.u. ml−1) was taken as an illustrative example. Depending on blood volume and starting bacterial concentration, the SLIC workflow may be quicker than indicated.

Fig. 6.

Discussion

The detection of BSI is one of the most important clinical investigations conducted by a clinical microbiology laboratory [10]. Cultivation of pathogens from the bloodstream remains the gold standard for the diagnosis of BSI [6]. Conventionally, the time taken to culture bacteria from the bloodstream is far greater than the time required for bacteria to replicate. A method, with a limit of detection close to that of the circulating levels found in a BSI patient (1–100 c.f.u. ml−1), is required [7,8].

In this study, we compared a commonly used automated blood culturing system with an innovative light scattering technology for the detection of Gram-negative BSI. We demonstrated that TTP was possible in a median time of 13.56 h (IQR, 10.57–19.66) when measured for over 100 Gram-negative BCs on the BacT/ALERT platform. The long time to positivity is in keeping with other studies which report BC positivity within 10–19 h using various automated blood culturing platforms [5,12,15, 31].

The current drawback of BSI diagnostics is the large bacterial concentration required before automated systems signal positive. Quantifying the concentration of flagged positive BCs on BacT/ALERT demonstrated a limit of detection of 108 c.f.u. ml−1. This agrees with other blood culturing systems such as the BACTEC FX which achieved similar detection sensitivities [32]. The limit of detection of these platforms is far greater than the bacterial concentration of 105 c.f.u. ml−1 required for bacterial identification and antibiotic susceptibility testing [33]. Evidently, the generation time of bacteria and the associated production rate of growth metabolites, which many automated blood culturing systems rely on, do not allow detectable bacterial growth in a rapid timeframe. The high bacterial concentration required for BC positivity negatively impacts the time to detection and the timeliness of downstream analysis. A limitation that can be overcome by developing and employing more sensitive methods for monitoring bacterial growth, such as light scatter.

Quantifying the effect of blood on bacterial generation time is challenging. However, the sensitivity of SLIC technology allowed this to be possible, thereby bridging a current gap in our knowledge. For most BSI pathogens (6/7), the generation time was prolonged in the presence of blood. This observed suppression of bacterial growth may be a combination of many mechanisms and may be non-specific or specific to each bacterial species [34,38]. The findings confirm the widespread assumption of the antibacterial effects of blood on bacterial growth [39].

The most frequent BSI pathogens isolated in clinical samples are E. coli and S. aureus [6]. The generation time of E. coli was constant at 20 min, whereas S. aureus replicated up to three times faster in BC than in nutrient-rich media. This observation is supported by a study conducted by Lee and colleagues [40] who documented a noticeable growth enhancement in S. aureus in blood compared with blood-free media [40]. This may be explained by the ability of S. aureus to utilize haemoglobin as an iron source through an internal iron-regulated surface determinant system, which has been reported as an essential requirement for S. aureus pathogenesis in BSI [37,41]. Additionally, this may offer an explanation as to why the generation time of S. aureus was enhanced in the presence of blood over other BSI pathogens where the utilization of haemoglobin is not uniform across bacterial pathogens [35,36].

Among the Gram-negative bacteria, E. coli is a predominant BSI pathogen and is implicated in 20–30 % of BSI cases worldwide [6,42, 43]. As such, this pathogen was selected to study the TTP on SLIC directly from BC and in a bid to facilitate point-of-care testing, whole blood. A variety of bacterial concentrations and blood volumes were tested on SLIC to reflect the low bacterial loads reported in BSI and to mimic blood volumes used in automated BC systems. For both sample types, the TTP was dependent on the starting bacterial concentration. From BC, SLIC offered rapid detection at all bacterial concentrations tested and TTP ranged from 15 to 85 min. The direct detection of bacteria from whole blood demonstrated a lag in bacterial growth with positivity determined between 6 and 9 h for a concentration range of 10–100 c.f.u. ml−1. In comparison, E. coli BC positivity was detectable in 12.3±3.7 h on the automated BacT/ALERT System. This demonstrates a promising timesaving could be made from BC and directly from whole blood using SLIC.

Facilitating testing directly from the patient sample can have a significant impact on the time to diagnosis and treatment. In this study, the pre-laboratory phase was associated with a meantime of 12.54±1.28 h and significantly prolonged the time to BC positivity and downstream analysis. The direct detection of E. coli from whole blood using SLIC demonstrated a potential timesaving of 76% compared with the standard workflow. This comparison was based on the most implicated BSI pathogen, E. coli, and at a bacterial concentration commonly isolated from BSI patients [6,8,42, 43]. The significance of reducing time to BSI diagnosis has been strongly correlated with enhanced patient care, reduced mortality and morbidity and has motivated the need for faster BSI diagnostics [20,44].

The TTP reported from BC and whole blood using SLIC was representative of E. coli only. It is appreciated that in other patient populations and clinical settings, different pathogens will be prevalent. Therefore, to support the use of SLIC as a rapid diagnostic tool in BSI, a larger multi-centre study incorporating a wide range of BSI pathogens and clinical patient samples is needed. Polymicrobial samples represent a small percentage of positive BCs, and the TTP reported are representative of monomicrobial growth only. Further work is needed to assess the impact of multiple pathogens in blood on the TTP using SLIC. The current prototype of SLIC has the capacity to screen six blood samples at one time, and this currently limits the way SLIC testing could be conducted in a clinical setting. Many BCs are requested, but few are positive with a low BC positivity rate of between 7.5 and 14.1% [45,46]. Thereby, to achieve a sufficient number of positive samples, it is likely that a larger cohort study from whole blood would need to be performed retrospectively.

Conclusion

In BSIs, rapid confirmation of bacterial growth will be valuable in the clinical decision-making of patient diagnosis and treatment. This is especially important for patients presenting with non-specific symptoms, a common occurrence in septic and BSI patients. The high sensitivity and the low limit of detection offered by SLIC supported a marked reduction in time to BC positivity over existing methods and made the direct detection of bacteria from BC and whole blood possible. The reduced number of steps to BSI detection and the advantages of phenotypic detection using SLIC including affordability, simplicity and rapidity presents a promising alternative BSI detection strategy supporting earlier diagnosis and better prognosis in BSI.

supplementary material

Uncited Table S1.
jmm-74-01942-s001.pdf (69.9KB, pdf)
DOI: 10.1099/jmm.0.001942

Acknowledgements

We are grateful to the Microbiology Department at Ninewells Hospital, Dundee, Scotland, for hosting the study and to the medical and laboratory staff who assisted and supported the research. We are equally grateful to Scottish Enterprise for their support and advice in the early stages of SLIC development and for making this research possible. The views expressed are those of the authors and not necessarily those of the NHS or the University of St Andrews.

Abbreviations

BC

blood culture

BHI

brain heart infusion

BSI

bloodstream infection

IQR

interquartile range

LS-SST

low-speed serum separation tube

mV

millivolts

SBCs

surrogate blood cultures

SLIC

Scattered Light Integrated Collection

TAT

turnaround time

TSB

tryptic soy broth

TTP

time to positivity

Footnotes

Funding: This work was funded by the University of St Andrews. The funders were not involved in the design, execution or reporting of the study.

Ethical statement: The study was reviewed and approved by the School of Medicine Ethics Committee at the University of St Andrews and by NHS Tayside Health Board. Informed consent was received from all healthy volunteers prior to blood donation. Healthy donor blood was spiked with bacteria to simulate blood samples from bacteraemia patients. The study used anonymized surplus patient samples for quantifying the bacterial load (c.f.u. ml-1) in blood culture. Patients were not recruited nor did they participate in the study.

Contributor Information

Kerry Falconer, Email: kerryjane.falconer@nhs.scot.

Robert Hammond, Email: rjhh@st-andrews.ac.uk.

Benjamin J. Parcell, Email: Benjamin.Parcell@nhs.scot.

Stephen H. Gillespie, Email: shg3@st-andrew.ac.uk.

References

  • 1.Timsit J-F, Soubirou J-F, Voiriot G, Chemam S, Neuville M, et al. Treatment of bloodstream infections in ICUs. BMC Infect Dis. 2014;14:489. doi: 10.1186/1471-2334-14-489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Viscoli C. Bloodstream infections: the peak of the iceberg. Virulence. 2016;7:248–251. doi: 10.1080/21505594.2016.1152440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Surrey and Sussex Healthcare NHS Trust Microbiology laboratory user’s manual. 2017. [9-January-2018]. https://www.surreyandsussex.nhs.uk/wp- content/uploads/2013/05/Microbiology-Laboratory-Users-Manual-Version-5.pdf accessed.
  • 4.Alder Hey Children’s NHS Foundation Trust A user’s guide to the medical microbiology department [accessed January 2018] 2017 http://www.alderhey.nhs.uk/wp- content/uploads/Microbiology-Lab-Handbook.pdf
  • 5.Altun O, Almuhayawi M, Lüthje P, Taha R, Ullberg M, et al. Controlled evaluation of the new BacT/Alert Virtuo blood culture system for detection and time to detection of bacteria and yeasts. J Clin Microbiol. 2016;54:1148–1151. doi: 10.1128/JCM.03362-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Public Health England UK standards for microbiology investigations: Investigation of blood cultures (for organisms other than Mycobacterium species) [accessed June 2020] 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attach ment_data/file/829758/B_37i8.2.pdf
  • 7.Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev. 1990;3:269–279. doi: 10.1128/CMR.3.3.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dorn GL, Land GA, Wilson GE. Improved blood culture technique based on centrifugation: clinical evaluation. J Clin Microbiol. 1979;9:391–396. doi: 10.1128/jcm.9.3.391-396.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yue P, Zhou M, Kudinha T, Xie X, Du J, et al. Clinical performance evaluation of VersaTrek 528 blood culture system in a Chinese tertiary hospital. Front Microbiol. 2018;9:2027. doi: 10.3389/fmicb.2018.02027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jorgensen JH, Pfaller MA, Carroll KC. Manual of Clinical Microbiology, 11th ed. Washington, DC: ASM Press; 2015. [Google Scholar]
  • 11.Opota O, Croxatto A, Prod’hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21:313–322. doi: 10.1016/j.cmi.2015.01.003. [DOI] [PubMed] [Google Scholar]
  • 12.Congestrì F, Pedna MF, Fantini M, Samuelli M, Schiavone P, et al. Comparison of “time to detection” values between BacT/ALERT VIRTUO and BacT/ALERT 3D instruments for clinical blood culture samples. Int J Infect Dis. 2017;62:1–5. doi: 10.1016/j.ijid.2017.06.012. [DOI] [PubMed] [Google Scholar]
  • 13.Anjana Gopi KL, Ravikumar MG, Ambarish NN, et al. Time to positivity of microorganisms with BACTEC 9050:- an 18-month study among children of 28 days to 60 months in an south indian tertiary hospital. Int J Microbiol Res. 2011;2:12–17. [Google Scholar]
  • 14.Riedel S, Eisinger SW, Dam L, Stamper PD, Carroll KC. Comparison of BD Bactec Plus Aerobic/F medium to VersaTREK Redox 1 blood culture medium for detection of Candida spp. in seeded blood culture specimens containing therapeutic levels of antifungal agents. J Clin Microbiol. 2011;49:1524–1529. doi: 10.1128/JCM.02260-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Samuel LP, Pimentel JD, Tibbetts RJ, Martin R, Hensley R, et al. Comparison of time to positivity of the VersaTREK® REDOX 80-mL and the REDOX EZ draw 40-mL blood culture bottles for common bacterial bloodstream pathogens. Diagn Microbiol Infect Dis. 2011;71:101–105. doi: 10.1016/j.diagmicrobio.2011.06.001. [DOI] [PubMed] [Google Scholar]
  • 16.Jiang J, Yang J, Mei J, Jin Y, Lu Y. Head-to-head comparison of qSOFA and SIRS criteria in predicting the mortality of infected patients in the emergency department: a meta-analysis. Scand J Trauma Resusc Emerg Med. 2018;26:56. doi: 10.1186/s13049-018-0527-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Daniels R, Nutbeam T., editors. The sepsis manual. 6th. 2022. edn. [Google Scholar]
  • 18.European Antimicrobial Resistance Surveillance Network (EARS-Net) Surveillance report: antimicrobial resistance in EU/EEA (EARS-Net) [18-March-2024];2022 https://www.ecdc.europa.eu/sites/default/files/documents/AER-antimicrobial-resistance.pdf accessed.
  • 19.O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. [14-March-2014];2016 https://amr- review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf accessed.
  • 20.Retamar P, Portillo MM, López-Prieto MD, Rodríguez-López F, de Cueto M, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56:472–478. doi: 10.1128/AAC.00462-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596. doi: 10.1097/01.CCM.0000217961.75225.E9. [DOI] [PubMed] [Google Scholar]
  • 22.Lodise TP, Jr, Patel N, Kwa A, Graves J, Furuno JP, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51:3510–3515. doi: 10.1128/AAC.00338-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38:1045–1053. doi: 10.1097/CCM.0b013e3181cc4824. [DOI] [PubMed] [Google Scholar]
  • 24.Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–4863. doi: 10.1128/AAC.00627-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lee C-C, Lee C-H, Hong M-Y, Tang H-J, Ko W-C. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care. 2017;21:119. doi: 10.1186/s13054-017-1696-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Robineau O, Robert J, Rabaud C, Bedos J-P, Varon E, et al. Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey) Infect Drug Resist. 2018;11:1359–1368. doi: 10.2147/IDR.S165877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hammond RJH, Falconer K, Powell T, Bowness R, Gillespie SH. A simple label-free method reveals bacterial growth dynamics and antibiotic action in real-time. Sci Rep. 2022;12:19393. doi: 10.1038/s41598-022-22671-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond) 1938;38:732–749. doi: 10.1017/s002217240001158x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.UK Health Security Agency UK standards for microbiology investigations. Sepsis and systemic or disseminated infections [accessed October 2024] 2023 https://www.rcpath.org/static/3f51b8e5-1ebe-469d-a79f3a3323bfaec9/7e38a3d1-fdc7-4c6e-aadc7e55b698ef26/uk-smi-s-12i1-sepsis-and-systemic-or-disseminated-infection-january-2023-pdf.pdf
  • 30.Falconer K, Hammond R, Gillespie SH. Improving the recovery and detection of bloodstream pathogens from blood culture. J Med Microbiol. 2020;69:806–811. doi: 10.1099/jmm.0.001209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ruiz-Giardín JM, Martin-Díaz RM, Jaqueti-Aroca J, Garcia-Arata I, San Martín-López JV, et al. Diagnosis of bacteraemia and growth times. Int J Infect Dis. 2015;41:6–10. doi: 10.1016/j.ijid.2015.10.008. [DOI] [PubMed] [Google Scholar]
  • 32.Wang M-C, Lin W-H, Yan J-J, Fang H-Y, Kuo T-H, et al. Early identification of microorganisms in blood culture prior to the detection of a positive signal in the BACTEC FX system using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. J Microbiol Immunol Infect. 2015;48:419–424. doi: 10.1016/j.jmii.2013.10.006. [DOI] [PubMed] [Google Scholar]
  • 33.EUCAST EUCAST reading guide for broth microdilution. Version 5. 2024. [18-March-2024]. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/MIC_testing/Reading_guide_BMD_v_5.0_2024.pdf accessed.
  • 34.Minasyan H. Erythrocyte and blood antibacterial defense. Eur J Immunol. 2014;4:138–143. doi: 10.1556/EuJMI.4.2014.2.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, et al. Specificity for human hemoglobin enhances Staphylococcus aureus Infection. Cell Host & Microbe. 2010;8:544–550. doi: 10.1016/j.chom.2010.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Pishchany G, Skaar EP. Taste for blood: hemoglobin as a nutrient source for pathogens. PLOS Pathog. 2012;8:e1002535. doi: 10.1371/journal.ppat.1002535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kim HK, DeDent A, Cheng AG, McAdow M, Bagnoli F, et al. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine. 2010;28:6382–6392. doi: 10.1016/j.vaccine.2010.02.097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Huddleson JF. Growth of bacteria in blood. use of cation exchange resins for enhancing or suppressing growth. Bulletin World Health Organisation. 1959;21:187–199. [PMC free article] [PubMed] [Google Scholar]
  • 39.Roome APCH, Tozer RA. Effect of dilution on the growth of bacteria from blood cultures. J Clin Pathol. 1968;21:719–721. doi: 10.1136/jcp.21.6.719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lee D-H, Koh E-H, Choi S-R, Kim S, Kim DH, et al. Effect of sodium citrate on growth of bacteria in blood culture. Ann Clin Microbiol. 2013;16:168. doi: 10.5145/ACM.2013.16.4.168. [DOI] [Google Scholar]
  • 41.Pishchany G, Haley KP, Skaar EP. Staphylococcus aureus growth using human hemoglobin as an iron source. J Vis Exp. 2013:50072. doi: 10.3791/50072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston KV, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63:e00355–19. doi: 10.1128/AAC.00355-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Buetti N, Atkinson A, Marschall J, et al. Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014. BMJ Open. 2017;7:e013665. doi: 10.1136/bmjopen-2016-013665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Kumar A, Ellis P, Arabi Y, Roberts D, Light B, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136:1237–1248. doi: 10.1378/chest.09-0087. [DOI] [PubMed] [Google Scholar]
  • 45.Nannan Panday RS, Wang S, van de Ven PM, Hekker TAM, Alam N, et al. Evaluation of blood culture epidemiology and efficiency in a large European teaching hospital. PLoS One. 2019;14:e0214052. doi: 10.1371/journal.pone.0214052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Falconer K, Hammond R, Parcell BJ, Gillespie SH. Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection device. J Med Microbiol. 2024;73:001812. doi: 10.1099/jmm.0.001812. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Uncited Table S1.
jmm-74-01942-s001.pdf (69.9KB, pdf)
DOI: 10.1099/jmm.0.001942

Data Availability Statement

Raw data were generated at the Ninewells Hospital, Dundee, and the University of St Andrews. Derived data supporting the findings of this study are available from the corresponding author (KF) on request.


Articles from Journal of Medical Microbiology are provided here courtesy of Microbiology Society

RESOURCES